Back to JNJ
Grantham, Mayo, Van Otterloo & Co. LLC → JNJ
Grantham, Mayo, Van Otterloo & Co. LLC JNJ Position History
Johnson & Johnson • Healthcare
Quarters held
18
Latest value
$1.8B
Q2 2026
Peak value
$1.8B
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $465M |
| Q1 2023 | $473K |
| Q2 2023 | $556.6M |
| Q2 2023 | $220K |
| Q3 2023 | $583.3M |
| Q4 2023 | $624.8M |
| Q1 2024 | $763.7M |
| Q2 2024 | $880.5M |
| Q3 2024 | $1B |
| Q4 2024 | $919.8M |
| Q1 2025 | $1.1B |
| Q2 2025 | $1B |
| Q3 2025 | $1.3B |
| Q4 2025 | $1.5B |
| Q1 2026 | $349K |
| Q1 2026 | $1.8B |
| Q2 2026 | $786K |
| Q2 2026 | $1.8B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.8B | 7.11M | — | — |
| Q2 2026 | $786K | 9.5K | — | — |
| Q1 2026 | $1.8B | 7.28M | — | — |
| Q1 2026 | $349K | 4.4K | — | — |
| Q4 2025 | $1.5B | 7.09M | — | — |
| Q3 2025 | $1.3B | 6.82M | — | — |
| Q2 2025 | $1B | 6.55M | — | — |
| Q1 2025 | $1.1B | 6.81M | — | — |
| Q4 2024 | $919.8M | 6.36M | — | — |
| Q3 2024 | $1B | 6.29M | — | — |
| Q2 2024 | $880.5M | 6.02M | — | — |
| Q1 2024 | $763.7M | 4.83M | — | — |
| Q4 2023 | $624.8M | 3.99M | — | — |
| Q3 2023 | $583.3M | 3.74M | — | — |
| Q2 2023 | $220K | 6.5K | — | — |
| Q2 2023 | $556.6M | 3.36M | — | — |
| Q1 2023 | $473K | 12.2K | — | — |
| Q1 2023 | $465M | 3.00M | — | — |
Other funds holding JNJ
$44.8B
$39.6B
$34.5B
$32.6B
$27.7B